期刊文献+
共找到288篇文章
< 1 2 15 >
每页显示 20 50 100
The adenoviral E1A protein relieves gene repression by receptors in v/vo displaces corepressors and unliganded thyroid hormone
1
作者 Yukiyasu Sato Andrew Ding +4 位作者 Rachel A Heimeier Ahmed F Yousef Joe S Mymryk Paul G Walfish Yun-Bo Shi 《Cell Research》 SCIE CAS CSCD 2009年第6期783-792,共10页
The human adenovirus type 5 early region 1A (E1A) is one of two oncogenes present in the adenovirus genome and functions by interfering with the activities of cellular regulatory proteins. The E1A gene is alternativ... The human adenovirus type 5 early region 1A (E1A) is one of two oncogenes present in the adenovirus genome and functions by interfering with the activities of cellular regulatory proteins. The E1A gene is alternatively spliced to yield five products. Earlier studies have revealed that E1A can regulate the function of thyroid hormone (T3) receptors (TRs). However, analysis in yeast compared with transfection studies in mammalian cell cultures yields surprisingly different effects. Here, we have examined the effect of E1A on TR function by using the frog oocyte in vivo system, where the effects of E1A can be studied in the context of chromatin. We demonstrate that different isoforms of E1A have distinct effects on TR function. The two longest forms inhibit both the repression by unliganded TR and activation by T3-bound TR. We further show that E1A binds to unliganded TR to displace the endogenous corepressor nuclear receptor corepressor, thus relieving the repression by unliganded TR. On the other hand, in the presence of T3, E1A inhibits gene activation by T3-bound TR indirectly, through a mechanism that requires its binding domain for the general coactivator p300. Taken together, our results thus indicate that E1A affects TR function through distinct mechanisms that are dependent upon the presence or absence of T3. 展开更多
关键词 adenoviral E1A thyroid hormone receptor COREPRESSOR COACTIVATOR CHROMATIN
下载PDF
Dose-dependent effect of parathyroid hormone 1-34 fragment and its influence mechanism on the functional activity of isolated heart
2
作者 Anna S. Ter-Markosyan Knarik R. Harutunyan +1 位作者 Rafik Sh. Sargsyan Drastamat N. Khudaverdyan 《Open Journal of Molecular and Integrative Physiology》 2012年第2期44-49,共6页
The present investigation is the continuation of our prior clinical studies on the content of parathyroid hormone (PTH), its paracrine analog, parathyroid hormone-related protein (PTHrP) and electrolytes in blood of p... The present investigation is the continuation of our prior clinical studies on the content of parathyroid hormone (PTH), its paracrine analog, parathyroid hormone-related protein (PTHrP) and electrolytes in blood of patients with heart failure. The results of these studies formed the basis for the nomination of the hypothesis on PTH and PTHrP compensatory-modulating effect on the contractile activity of heart. The objective of this study is to elucidate the mechanism of the compensatory-modulating effect of PTH on heart functional activity, which is realized by the study of effective doses of PTH by pharmacological analysis, using different inhibitors. The dose-dependent effect of PTH on the heart contraction rate and amplitude is studied on the frog isolated heart by the method of non-invasive registration of heart contractile activity. The method is based on the photoelectric principle of the reflected from the contractile object light ray transformation into an electric signaling. It is shown that the most effective dose that has positive chronotropic and inotropic effects on heart is 10–10 M hormone. To clarify the mechanism of PTH physiological dose action on the contractile activity of heart PTH 1-34 is combined with Ca-channel as well as phosphodiesterase blockers. The mentioned substances are applied based on the fact that PTH effect on target cells is mediated by secondary messengers, particularly calcium ions and cAMP. Based on the data obtained by combination of hormone with Verapamil (10–5 M) and Theophylline (10–4 M), we concluded on the involvement of calcium ions in the realization of chronotropic and cAMP in the inotropic effects on the heart. 展开更多
关键词 1-34 parathyroid hormone Isolated HEART Calcium CAMP
下载PDF
食管癌术后肾上腺危象1例并文献复习
3
作者 贺小旭 李周平 +2 位作者 刘音 饶芝国 薛晓艳 《中国合理用药探索》 CAS 2024年第1期40-44,共5页
目的:探讨肾上腺危象(AC)的临床特征及诊疗要点,减少临床工作中的漏诊、误诊、误治。方法:回顾性分析1例食管癌术后合并AC的临床资料,总结AC的临床诊治经过。结果:患者为49岁男性,因食管癌术后3周出现发热入院,存在吻合口瘘,给予多种抗... 目的:探讨肾上腺危象(AC)的临床特征及诊疗要点,减少临床工作中的漏诊、误诊、误治。方法:回顾性分析1例食管癌术后合并AC的临床资料,总结AC的临床诊治经过。结果:患者为49岁男性,因食管癌术后3周出现发热入院,存在吻合口瘘,给予多种抗菌药物长时间抗感染治疗效果不佳,即使瘘口愈合后仍间断高热、血压下降。患者偶用激素退热治疗后效果较好,但减量停用后患者逐渐乏力、卧床。查增强计算机断层扫描(CT)未见肿瘤复发,皮质醇、促肾上腺皮质激素(ACTH)明显偏低,结合术前曾应用程序性死亡受体1(PD-1)抑制剂,明确诊断为免疫治疗相关垂体炎,进而导致了AC,补充醋酸泼尼松片后好转出院。结论:AC是一种危急的内科急症,临床表现缺乏特异性,极容易漏诊、误诊、误治,临床医生应加强对本病的认识,从而达到早期诊断并能及时给予糖皮质激素治疗的目的。 展开更多
关键词 肾上腺危象 急性肾上腺皮质功能不全 脓毒症 促肾上腺皮质激素 程序性死亡受体1
下载PDF
^(131)I治疗对分化型甲状腺癌患者术后血清iPTH、IGF-1水平的影响
4
作者 王宁 刘金彪 乔楠 《河南医学研究》 CAS 2024年第14期2565-2568,共4页
目的探讨^(131)I治疗对分化型甲状腺癌患者术后血清全段甲状旁腺激素(iPTH)、胰岛素样生长因子1(IGF-1)水平的影响。方法回顾性分析河南科技大学第一附属医院2020年1月至2022年9月收治的73例分化型甲状腺癌患者,均接受甲状腺全切除并于... 目的探讨^(131)I治疗对分化型甲状腺癌患者术后血清全段甲状旁腺激素(iPTH)、胰岛素样生长因子1(IGF-1)水平的影响。方法回顾性分析河南科技大学第一附属医院2020年1月至2022年9月收治的73例分化型甲状腺癌患者,均接受甲状腺全切除并于术后2个月采用^(131)I治疗,随访1个月根据治疗情况将患者分为有效组(51例)和无效组(22例)。比较两组患者治疗前及治疗7 d iPTH和IGF-1水平,以及有效组治疗后各时间点血清iPTH、IGF-1水平。结果两组患者治疗后7 d血清iPTH、IGF-1水平均低于治疗前,且有效组低于无效组(P<0.05);有效组治疗后不同时间点血清iPTH、IGF-1水平差异有统计学意义(P<0.05)。结论分化型甲状腺癌患者^(131)I治疗后血清iPTH、IGF-1水平变化可用于判断甲状旁腺功能恢复情况,血清iPTH还可预示术后低钙血症的发生。 展开更多
关键词 甲状腺癌 ^(131)I治疗 全段甲状旁腺激素 胰岛素样生长因子1
下载PDF
甲状旁腺激素(1-34)对老年股骨颈骨折合并骨质疏松症患者的疗效
5
作者 苗江科 张志乾 《深圳中西医结合杂志》 2024年第2期118-120,共3页
目的:探究甲状旁腺激素(1-34)联合空心钉在老年股骨颈骨折合并骨质疏松症患者中的临床疗效。方法:选取2020年7月至2021年7月济源市人民医院收治的老年股骨颈骨折合并骨质疏松症患者80例,随机分为观察组和对照组,各40例。对照组患者给予... 目的:探究甲状旁腺激素(1-34)联合空心钉在老年股骨颈骨折合并骨质疏松症患者中的临床疗效。方法:选取2020年7月至2021年7月济源市人民医院收治的老年股骨颈骨折合并骨质疏松症患者80例,随机分为观察组和对照组,各40例。对照组患者给予空心钉治疗,观察组患者采用甲状旁腺激素(1-34)联合空心钉治疗。观察并比较两组患者骨折愈合时间、出院时间、疼痛评分、髋关节功能评分、骨密度水平及生活质量评分。结果:观察组患者骨折愈合时间、出院时间短于对照组,疼痛评分低于对照组,髋关节功能评分及骨密度水平高于对照组,差异均具有统计学意义(P<0.05)。结论:甲状旁腺激素(1-34)联合空心钉治疗方案应用于老年股骨颈骨折合并骨质疏松症患者可获得较好的临床疗效,相较于单用空心钉治疗,患者康复的时间更短,治疗后疼痛症状缓解显著,髋关节功能及骨密度水平改善效果好。 展开更多
关键词 股骨颈骨折 骨质疏松症 甲状旁腺激素(1-34) 空心钉 老年人
下载PDF
Hypoxia-inducible factor-1a restricts the anabolic actions of parathyroid hormone 被引量:2
6
作者 Julie L Frey David P Stonko +1 位作者 Marie-Claude Faugere Ryan C Riddle 《Bone Research》 SCIE CAS 2014年第1期33-42,共10页
The hypoxia inducible factors (Hifs) are evolutionarily conserved transcriptional factors that control homeostatic responses to low oxygen. In developing bone, Hif-1 generated signals induce angiogenesis necessary f... The hypoxia inducible factors (Hifs) are evolutionarily conserved transcriptional factors that control homeostatic responses to low oxygen. In developing bone, Hif-1 generated signals induce angiogenesis necessary for osteoblast specification, but in mature bone, loss of Hif-1 in osteoblasts resulted in a more rapid accumulation of bone. These findings suggested that Hif-1 exerts distinct developmental functions and acts as a negative regulator of bone formation. To investigate the function of Hif-1a in osteoanabolic signaling, we assessed the effect of Hif-1a loss-of-function on bone formation in response to intermittent parathyroid hormone (PTH). Mice lacking Hif-1a in osteoblasts and osteocytes form more bone in response to PTH, likely through a larger increase in osteoblast activity and increased sensitivity to the hormone. Consistent with this effect, exposure of primary mouse osteoblasts to PTH resulted in the rapid induction of Hif-1a protein levels via a post-transcriptional mechanism. The enhanced anabolic response appears to result from the removal of Hif-1a-mediated suppression of β-catenin transcriptional activity. Together, these data indicate that Hif-1a functions in the mature skeleton to restrict osteoanabolic signaling. The availability of pharmacological agents that reduce Hif-1a function suggests the value in further exploration of this pathway to optimize the therapeutic benefits of PTH. 展开更多
关键词 PTH Hypoxia-inducible factor-1a restricts the anabolic actions of parathyroid hormone FIGURE
下载PDF
BALP、PTH、IGF-1联合检测在肾性骨病诊断中的应用价值
7
作者 李小龙 温洁 《临床医学研究与实践》 2024年第30期89-92,共4页
目的探讨骨碱性磷酸酶(BALP)、甲状旁腺激素(PTH)、胰岛素样生长因子-1(IGF-1)联合检测在肾性骨病(ROD)诊断中的应用价值。方法选择2020年1月至2022年12月就诊于本院的90例ROD患者纳入ROD组,另选取同期本院90例健康体检者纳入对照组。... 目的探讨骨碱性磷酸酶(BALP)、甲状旁腺激素(PTH)、胰岛素样生长因子-1(IGF-1)联合检测在肾性骨病(ROD)诊断中的应用价值。方法选择2020年1月至2022年12月就诊于本院的90例ROD患者纳入ROD组,另选取同期本院90例健康体检者纳入对照组。两组均接受血清学指标及骨密度检测,比较两组的检测结果,分析血清学指标与骨密度的相关性,探究BALP、PTH、IGF-1单独及联合检测对ROD的诊断效能。结果ROD组的BALP、PTH水平高于对照组,IGF-1水平以及腰椎、股骨近端骨密度低于对照组,差异具有统计学意义(P<0.05)。经Pearson相关性分析,ROD组的BALP、PTH水平与骨密度呈负相关,IGF-1水平与骨密度呈正相关(r=-0.651、-0.553、0.467,P<0.001)。联合检测诊断ROD的灵敏度、特异度、阴性预测值及准确度高于BALP、PTH、IGF-1单独检测,阳性预测值高于BALP、PTH单独检测,差异具有统计学意义(P<0.05)。结论ROD患者与健康人群的BALP、PTH、IGF-1水平存在显著差异,ROD患者的BALP、PTH、IGF-1水平与骨密度存在密切关系,联合检测能够提高ROD的诊断效能,临床可将其用于ROD的辅助诊断。 展开更多
关键词 骨碱性磷酸酶 甲状旁腺激素 胰岛素样生长因子-1 肾性骨病
下载PDF
THR mRNA、ALCAT1在甲亢性心脏病中的协同诊断作用
8
作者 张晓玲 金瑶 +1 位作者 李素芳 彭海英 《检验医学》 CAS 2024年第1期60-67,共8页
目的探讨甲状腺激素受体(THR)mRNA、心磷脂酰基转移酶1(ALCAT1)在甲亢性心脏病中的临床意义。方法选取2020年2月—2022年3月张家口市妇幼保健院甲亢性心脏病患者69例(甲亢性心脏病组)、单纯甲状腺功能亢进患者69例(单纯甲亢组)、非甲亢... 目的探讨甲状腺激素受体(THR)mRNA、心磷脂酰基转移酶1(ALCAT1)在甲亢性心脏病中的临床意义。方法选取2020年2月—2022年3月张家口市妇幼保健院甲亢性心脏病患者69例(甲亢性心脏病组)、单纯甲状腺功能亢进患者69例(单纯甲亢组)、非甲亢性心脏病患者69例(非甲亢性心脏病组)和健康体检者69名(正常对照组)。收集所有研究对象的一般资料和实验室检测结果,并检测THRα1 mRNA、THRβ1 mRNA和ALCAT1。采用Logistic回归分析评估甲亢性心脏病发生的危险因素。采用相对超危险度比(RERI)、归因比(AP)和交互作用指数(SI)分析THR mRNA、ALCAT1在甲亢性心脏病发生中的交互作用。采用受试者工作特征(ROC)曲线评价THR mRNA、ALCAT1诊断甲亢性心脏病的效能。结果甲亢性心脏病组THRβ1 mRNA相对表达量和ALCAT1水平高于单纯甲亢组(P<0.001),THRα1 mRNA、THRβ1 mRNA相对表达量和ALCAT1水平高于非甲亢性心脏病组、正常对照组(P<0.001)。单纯甲亢组THRα1 mRNA、THRβ1 mRNA相对表达量和ALCAT1水平高于非甲亢性心脏病组、正常对照组(P<0.05),非甲亢性心脏病组THRα1 mRNA、THRβ1 mRNA相对表达量和ALCAT1水平高于正常对照组(P<0.05)。多因素Logistic回归分析结果显示,校正甲状腺功能亢进病程、游离三碘甲状腺原氨酸(FT_(3))、游离甲状腺素(FT_(4))、促甲状腺激素(TSH)、总三碘甲状腺原氨酸(TT_(3))、总甲状腺素(TT_(4))后,THRβ1 mRNA相对表达量和ALCAT1水平升高是甲亢性心脏病发生的危险因素[比值比(OR)值分别为3.185、3.712,95%可信区间(CI)分别为1.524~6.658、1.967~7.006,P<0.001]。THRβ1 mRNA与ALCAT1对甲亢性心脏病的发生存在正向交互作用,二者均高表达时甲亢性心脏病风险是二者均低表达时的9.000倍;二者同时高表达时甲亢性心脏病风险是其他未知因子(其OR=1)的3.148倍(RERI=3.148);协同效应是二者单独存在产生效应之和的1.855倍(SI=1.855);在二者共存的甲亢性心脏病风险中,有34.98%(AP=34.98%)由二者交互作用引起。ROC曲线分析结果显示,THRβ1 mRNA、ALCAT1单项检测和联合检测诊断甲亢性心脏病的曲线下面积(AUC)分别为0.798、0.726、0.872。结论THRβ1 mRNA、ALCAT1是甲亢性心脏病的独立危险因素,且对甲亢性心脏病的发生具有协同促进作用,二者联合检测可提升对甲亢性心脏病的诊断效能。 展开更多
关键词 甲状腺激素受体 心磷脂酰基转移酶1 甲亢性心脏病 交互作用
下载PDF
PTH-HIF1α-EPO信号通路促进慢性肾病患者肾性贫血的机制
9
作者 吴勐 刘莲芝 +4 位作者 邓金秀 钟少榕 丘昭文 章宇 林冲云 《贵州医科大学学报》 CAS 2024年第10期1484-1489,共6页
目的探讨甲状旁腺激素(PTH)-低氧诱导因1α(HIF1α)-红细胞生成素(EPO)信号通路在促进慢性肾脏病(CKD)肾性贫血中的作用机制。方法12只6~8周龄的C57BL/6雄性小鼠随机均分为健康小鼠(对照)组及CKD小鼠(CKD模型)组,CKD小鼠组采用5/6肾切... 目的探讨甲状旁腺激素(PTH)-低氧诱导因1α(HIF1α)-红细胞生成素(EPO)信号通路在促进慢性肾脏病(CKD)肾性贫血中的作用机制。方法12只6~8周龄的C57BL/6雄性小鼠随机均分为健康小鼠(对照)组及CKD小鼠(CKD模型)组,CKD小鼠组采用5/6肾切除法构建CKD模型,1周后再随机均分为两组、分别腹腔注射磷酸盐缓冲液(PBS)和Deferoxamine;4周后收集各组小鼠血液和肾脏标本,检测小鼠红细胞计数、血红蛋白、血肌酐、尿素氮、尿酸及PTH含量,聚合酶链反应(PCR)检测肾脏组织HIF1α及EPO mRNA表达水平,蛋白印迹法检测肾脏组织热休克蛋白90(HSP90)及Rho相关卷曲螺旋结构蛋白激酶1(ROCK1)蛋白表达水平。结果与健康小鼠组相比,CKD小鼠组血清尿素氮、肌酐、尿酸、PTH水平增高(P<0.05),红细胞计数及血红蛋白含量下降(P<0.05);CKD小鼠组肾脏组织中HIF1α及EPO mRNA表达水平降低(P<0.05);与注射PBS的CKD小鼠组相比,注射Deferoxamine后的CKD小鼠组红细胞数量及血红蛋白含量升高(P<0.05);与健康小鼠组相比,CKD小鼠组HSP90和ROCK1的蛋白表达水平下降(P<0.05)。结论PTH可能通过调节Ras同源家族成员A(RhoA)-Rock影响HIF1α的表达,PTH-HIF1α-EPO信号通路可能是导致CKD患者肾性贫血发生的机制。 展开更多
关键词 甲状旁腺激素 低氧诱导因1α 促红细胞生成素 慢性肾脏病 肾性贫血 热休克蛋白90 Rho相关卷曲螺旋结构蛋白激酶1
下载PDF
DAWNA-1研究:达尔西利联合氟维司群治疗HR+/HER2-晚期乳腺癌的疗效分析 被引量:1
10
作者 汪颖 张晓祺 《循证医学》 2023年第2期83-87,共5页
1文献来源Xu B,Zhang Q,Zhang P,et al.Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer:a randomized,phase 3 trial[J].Nat Med,2021,27(11):1904-1909.2证据水平1b。
关键词 达尔西利 激素受体阳性乳腺癌 DAWNA-1研究
下载PDF
CRHR1基因rs242941位点多态性与哮喘儿童ICS 长期安全用药的关系
11
作者 严慧 吴小磊 +2 位作者 王兰英 彭建霞 洪源 《国际检验医学杂志》 CAS 2023年第16期1953-1957,共5页
目的研究促肾上腺皮质激素释放激素受体1(CRHR1)基因rs242941位点的多态性与哮喘儿童吸入性糖皮质激素(ICS)长期安全用药的关系。方法选取2018年10月至2020年10月该院收治的100例哮喘儿童,均接受ICS治疗及常规对症治疗。采用TaqMan法检... 目的研究促肾上腺皮质激素释放激素受体1(CRHR1)基因rs242941位点的多态性与哮喘儿童吸入性糖皮质激素(ICS)长期安全用药的关系。方法选取2018年10月至2020年10月该院收治的100例哮喘儿童,均接受ICS治疗及常规对症治疗。采用TaqMan法检测CRHR1基因rs242941位点多态性,根据基因型分为GG、GT+TT,比较不同基因型患儿的肺功能、哮喘控制测试评分及不良反应发生情况。采用多因素Logistic回归分析影响哮喘儿童ICS安全用药的危险因素。结果CRHR1基因rs242941位点存在3种基因型:GG(72例)、GT(20例)、TT(8例),G和T等位基因频率分别为82%和18%。治疗12周后不同基因型患儿的哮喘控制测试评分、第1秒用力呼气容积(FEV1)、FEV1/用力肺活量(FVC)比值与治疗前比较均明显提升,其中GG基因型患儿改善情况优于GT+TT基因型,GG基因型患儿的症状及体征完全缓解时间明显短于GT+TT基因型,差异有统计学意义(P<0.05)。GG基因型不良反应发生率低于GT+TT基因型,差异有统计学意义(P<0.05)。单因素、多因素Logistic回归分析显示,rs242941位点基因型多态性是影响患者用药安全的独立危险因素(P<0.05)。结论CRHR1基因rs242941位点多态性与哮喘儿童ICS的疗效及长期用药安全性密切关联,其中TT基因型患儿具有更高的ICS不良反应发生风险。 展开更多
关键词 促肾上腺皮质激素释放激素受体1 基因多态性 哮喘 吸入性糖皮质激素 用药安全
下载PDF
Osteoporotic fracture and parathyroid hormone 被引量:14
12
作者 Nabanita S Datta 《World Journal of Orthopedics》 2011年第8期67-74,共8页
Osteoporosis and age-related bone loss is associated with changes in bone remodeling characterized by decreased bone formation relative to bone resorption,resulting in bone fragility and increased risk of fractures.St... Osteoporosis and age-related bone loss is associated with changes in bone remodeling characterized by decreased bone formation relative to bone resorption,resulting in bone fragility and increased risk of fractures.Stimulating the function of bone-forming osteoblasts,is the preferred pharmacological intervention for osteoporosis.Recombinant parathyroid hormone(PTH),PTH(1-34),is an anabolic agent with proven benefits to bone strength and has been characterized as a potential therapy for skeletal repair.In spite of PTH’s clinical use,safety is a major consideration for long-term treatment.Studies have demonstrated that intermittent PTH treatment enhances and accelerates the skeletal repair process via a number of mechanisms.Recent research into the molecular mechanism of PTH action on bone tissue has led to the development of PTH analogs to control osteoporotic fractures.This review summarizes a number of advances made in the field of PTH and bone fracture to combat these injuries in humans and in animal models.The ultimate goal of providing an alternative to PTH,currently the sole anabolic therapy in clinical use,to promote bone formation and improve bone strength in the aging population is yet to be achieved. 展开更多
关键词 OSTEOPOROSIS Fracture repair parathyroid hormone parathyroid hormone-1 receptor Emerging THERAPIES
下载PDF
Effect of sericin on diabetic hippocampal growth hormone/insulin-like growth factor 1 axis 被引量:2
13
作者 Zhihong Chen Songhe Yang +2 位作者 Yaqiang He Chengjun Song Yongping Liu 《Neural Regeneration Research》 SCIE CAS CSCD 2013年第19期1756-1764,共9页
Previous studies have shown that sericin extracted from silk cocoon significantly reduces blood glucose levels and protects the nervous system against diabetes mellitus. In this study, a rat type 2 diabetes mellitus m... Previous studies have shown that sericin extracted from silk cocoon significantly reduces blood glucose levels and protects the nervous system against diabetes mellitus. In this study, a rat type 2 diabetes mellitus model was established by intraperitoneal injection of 25 mg/kg streptozotocin for 3 successive days, following which the rats were treated with sericin for 35 days. After treatment, the blood glucose levels of the diabetic rats decreased significantly, the growth hormone level in serum and its expression in the hippocampus decreased significantly, while the insulin-like growth factor-1 level in serum and insulin-like growth factor-1 and growth hormone receptor expression in the hippocampus increased significantly. The experimental findings indicate that sericin improves disorders of the growth hormone/insulin-like growth factor 1 axis to alleviate hippocampal damage in diabetic rats. 展开更多
关键词 neural regeneration traditional Chinese medicine SERICIN type 2 diabetes mellitus hippocampus growth hormone insulin-like growth factor 1 growth hormone receptor growth hormone/insulin-likegrowth factor 1 axis STREPTOZOTOCIN blood glucose western blot assay reverse transcription-PCR grants-supported paper NEUROREGENERATION
下载PDF
MiR-301a-5p调节继发性甲状旁腺功能亢进症中甲状旁腺激素的分泌:基于调控钙敏感受体的表达 被引量:1
14
作者 柳丽丹 钱立元 +5 位作者 李珮婷 李俊 黄珊 易文君 柳双喜 吴唯 《南方医科大学学报》 CAS CSCD 北大核心 2023年第8期1363-1370,共8页
目的探索继发性甲状旁腺功能亢进症(SHPT)中引起钙敏感受体(CaSR)低表达的miRNA及其对甲状旁腺激素(PTH)分泌的影响。方法对6例正常甲状旁腺组织标本和11例SHPT的甲状旁腺组织标本进行了全转录组测序,结合网站的预测,初步筛选了7个有可... 目的探索继发性甲状旁腺功能亢进症(SHPT)中引起钙敏感受体(CaSR)低表达的miRNA及其对甲状旁腺激素(PTH)分泌的影响。方法对6例正常甲状旁腺组织标本和11例SHPT的甲状旁腺组织标本进行了全转录组测序,结合网站的预测,初步筛选了7个有可能调控CaSR的miRNAs,通过双荧光素酶实验,选定出一个最可能调控CaSR的miRNA。采用qRT-PCR检测正常甲状旁腺组织与SHPT甲状旁腺组织中miR-301a-5p和CaSR信使RNA表达的差异,并分析其表达量与患者血清PTH水平的相关性。采用Western blot检测SHPT甲状旁腺原代细胞转染miR-301a-5p mimics、inhibitors及各自对照之后CaSR蛋白表达的情况,同时取其上清液测定PTH的分泌情况。结果初步选定了7个有可能调控CaSR的miRNAs,分别是:miR-15a-5p、miR-15b-5p、miR-16-5p、miR-221-3p、miR-222-3p、miR-301a-5p和miR-503-5p。与正常甲状旁腺组织相比,miR-301a-5p在SHPT中表达上调(P<0.05),其表达量与患者PTH水平呈正相关关系,但结果无统计学意义(P>0.05);而CaSR信使RNA表达下调(P<0.05),其表达量与患者PTH水平呈负相关关系,但结果无统计学意义(P>0.05)。在细胞实验中,当miR-301a-5p过表达时,SHPT甲状旁腺原代细胞中CaSR蛋白的表达较对照组减少(P<0.05);反之,当miR-301a-5p的表达被抑制时,CaSR蛋白的表达较对照组增加(P<0.05)。过表达miR-301a-5p后,PTH的分泌与对照组的差异无统计学意义(P>0.05),而拮抗miR-301a-5p的表达后,PTH的分泌较对照组增加(P<0.05)。结论miR-301a-5p可能通过调控SHPT中CaSR的表达而影响PTH的分泌。 展开更多
关键词 继发性甲状旁腺功能亢进症 钙敏感受体 甲状旁腺激素 miR-301a-5p
下载PDF
PTHR1调控VEGF干预骨肉瘤组织血管形成及增殖的机制研究 被引量:2
15
作者 岳家吉 李盛龙 +1 位作者 孙维超 孙炜 《中国肿瘤临床》 CAS CSCD 北大核心 2023年第7期331-335,共5页
目的:通过分析临床样本构建细胞转染调控模型,分析甲状旁腺激素1型受体(parathyroid hormone type 1 receptor,PTHR1)调控骨肉瘤血管生成和增殖的分子机制,为骨肉瘤的治疗提供新的临床思路。方法:分析2017年1月至2019年12月就诊于大连... 目的:通过分析临床样本构建细胞转染调控模型,分析甲状旁腺激素1型受体(parathyroid hormone type 1 receptor,PTHR1)调控骨肉瘤血管生成和增殖的分子机制,为骨肉瘤的治疗提供新的临床思路。方法:分析2017年1月至2019年12月就诊于大连理工大学附属肿瘤医院(辽宁省肿瘤医院)与深圳市第二人民医院(深圳大学附属第一医院),经组织病理学确认的四肢经典型骨肉瘤患者临床样本共50例,构建PTHR1沉默的骨肉瘤细胞模型,分析PTHR1在肿瘤组织样本中的差异表达,探索PTHR1表达水平与肿瘤增殖及患者生存率之间的相关性。通过体外实验下调PTHR1表达,分析其对血管生成的调控作用。结果:在骨肉瘤患者的临床样本中,PTHR1在肿瘤组织中的表达量显著高于瘤旁组织,且随着PTHR1表达量显著增高,患者肿瘤体积的增大,远期生存率下降。术后36个月生存率,PTHR1高表达组患者显著低于低表达组。在体外实验中,通过沉默PTHR1表达可以有效降低血管生成素血管内皮生长因子(vascular endothelial growth factor,VEGF)表达,抑制肿瘤细胞增殖,在鸡胚胎卵黄囊模型中,抑制骨肉瘤细胞的血管生成能力。结论:PTHR1在肿瘤组织中显著高表达,且与肿瘤增殖及远期生存具有显著相关性,抑制PTHR1可降低骨肉瘤组织血管生成作用。 展开更多
关键词 骨肉瘤 甲状旁腺激素 1型受体 增殖 血管生成
下载PDF
甲状旁腺激素1型受体在肾脏疾病中的研究进展 被引量:1
16
作者 鄢鹏 宋健玲 房向东 《中国全科医学》 CAS 北大核心 2023年第11期1398-1403,共6页
甲状旁腺激素1型受体(PTH1R)是G蛋白偶联受体家族成员之一,在体内广泛表达,参与体内胚胎发育、钙磷稳态、机体代谢、肿瘤发生等多种过程。PTH1R在肾脏中高度表达,PTH1R的活化可涉及多种复杂机制,参与肾脏疾病的发生、发展,与多种肾脏疾... 甲状旁腺激素1型受体(PTH1R)是G蛋白偶联受体家族成员之一,在体内广泛表达,参与体内胚胎发育、钙磷稳态、机体代谢、肿瘤发生等多种过程。PTH1R在肾脏中高度表达,PTH1R的活化可涉及多种复杂机制,参与肾脏疾病的发生、发展,与多种肾脏疾病如糖尿病肾病、肾小球肾炎、急性肾损伤、慢性肾脏病等关系密切。本文就PTH1R功能及其在肾脏疾病中发挥的作用和机制进行综述,深入探讨PTH1R与肾脏疾病的关系和相关机制,以期为肾脏疾病的诊断和治疗提供新思路。 展开更多
关键词 肾疾病 受体 甲状旁腺激素 1 甲状旁腺激素相关蛋白质 甲状旁腺激素 糖尿病肾病 肾小球肾炎 慢性肾脏病 急性肾损伤 综述
下载PDF
Inhibition effects of parathyroid hormone on human medullary thyroid carcinoma cells 被引量:1
17
作者 Yaqiong Ni Qinjiang Liu +1 位作者 Shihong Ma Ruihui Chen 《The Chinese-German Journal of Clinical Oncology》 CAS 2014年第5期224-228,共5页
Objective: The purpose of the study was to investigate the effects of parathyroid hormone and parathyroid hormone receptor monoclonal antibody on in vitro growth and proliferation of human medullary thyroid carcinoma... Objective: The purpose of the study was to investigate the effects of parathyroid hormone and parathyroid hormone receptor monoclonal antibody on in vitro growth and proliferation of human medullary thyroid carcinoma cell lines. Methods: The medullary thyroid carcinoma cell line was cultured in vitro, with parathyroid hormone and parathyroid hormone receptor monoclonal antibody treatment intervention, the growth of the cells was observed under an inverted contrast micro scope, the MTT assay was used to detect the cell growth inhibition rate. Results: Under the inverted contrast microscope, the cells changed significantly, the parathyroid hormone and parathyroid hormone receptor monoclonal antibodies can effectively inhibit the proliferation of medullary thyroid cancer cells in a time and dose dependent. When parathyroid hormone concentra tion reached a concentration of 2.0 IJmol/L, the parathyroid hormone receptor monoclonal antibody reached a concentration of 1.0 μmol/L, the cell growth was most significantly inhibited (P 〈 0.05). Conclusion: Parathyroid hormone and parathyroid hormone receptor monoclonal antibody were able to inhibit the proliferation of medullary thyroid carcinoma cells and signifi cantly reduce the proliferation index. 展开更多
关键词 parathyroid hormone (PTH) medullary thyroid carcinoma (MTC) cell line parathyroid hormone receptor mono-clonal antibody
下载PDF
甲状旁腺激素受体1基因相关与原发性牙齿萌出障碍的研究进展 被引量:1
18
作者 余岳霖 孔卫东 《国际口腔医学杂志》 CAS CSCD 2023年第5期573-580,共8页
原发性牙齿萌出障碍(PFE)是一种罕见的常染色体显性遗传性疾病,主要表现为单侧或双侧后牙区开,无明显局部阻碍因素和全身因素,主要与患者牙齿萌出机制异常有关。目前研究认为其病因与甲状旁腺激素受体1(PTH1R)基因突变有密切联系,但... 原发性牙齿萌出障碍(PFE)是一种罕见的常染色体显性遗传性疾病,主要表现为单侧或双侧后牙区开,无明显局部阻碍因素和全身因素,主要与患者牙齿萌出机制异常有关。目前研究认为其病因与甲状旁腺激素受体1(PTH1R)基因突变有密切联系,但其背后的致病机制还有待阐明。本文就与PFE发病相关的热点基因PTH1R信号缺陷与破骨细胞功能、牙囊发育、牙槽骨形成、牙周膜形成、牙根形成的研究现状进行综述,意为PFE的病因遗传学及分子机制的研究提供参考。 展开更多
关键词 原发性牙齿萌出障碍 甲状旁腺激素受体1 破骨细胞 牙囊 牙槽骨 牙周膜
下载PDF
Involvement of chromatin and histone acetylation in the regulation of HIV-LTR by thyroid hormone receptor 被引量:4
19
作者 HsiaSC WangH 《Cell Research》 SCIE CAS CSCD 2001年第1期8-16,共9页
The HIV-1 LTR controls the expression of HIV-1 viral genes and thus is critical for viral propagation and pathology. Numerous host factors have been shown to participate in the regulation of the LTR promoter. Among th... The HIV-1 LTR controls the expression of HIV-1 viral genes and thus is critical for viral propagation and pathology. Numerous host factors have been shown to participate in the regulation of the LTR promoter. Among them is the thyroid hormone (T3) receptor (TR). TR has been shown to bind to the critical region of the promoter that contain the NFbB and Sp1 binding sites. Interestingly, earlier transient transfection studies in tissue culture cells have yielded contradicting conclusions on the role of TR in LTR regulation, likely due to the use of different cell types and/or lack of proper chromatin organization. Here, using the frog oocyte as a model system that allows replication-coupled chromatin assembly, mimicking that in somatic cells, we demonstrate that unliganded heterodimers of TR and RXR (9-cis retinoic acid receptor) repress LTR while the addition of T3 relieves the repression and further activates the promoter. More importantly, we show that chromatin and unliganded TR/RXR synergize to repress the promoter in a histone deacetylase-dependent manner. 展开更多
关键词 ACETYLATION Acquired Immunodeficiency Syndrome Animals CHROMATIN DIMERIZATION Gene Expression Regulation Viral HIV Long Terminal Repeat HIV-1 Histone Deacetylases HISTONES Ligands NF-kappa B OOCYTES receptors Retinoic Acid receptors Thyroid hormone Response Elements Retinoid X receptors Transcription Factors Xenopus laevis
下载PDF
Cloning and Expression Level Analysis of Melanocyte-stimulating Hormone Receptor 1 Gene(MC1R) in Alpacas with Different Coat Color
20
作者 REN Yu-hong REN Bin +4 位作者 FAN Rui-wen ZHU Zhi-wei YANG Yong LI Hui DONG Chang-sheng 《畜牧兽医学报》 CAS CSCD 北大核心 2010年第S1期21-25,共5页
Specific primers for the MC1R gene of alpacas(GenBank EU1358800) were designed to amplify the cDNA sequence using RT-PCR to seek variation in the sequence and explore the relationship between the expression level of M... Specific primers for the MC1R gene of alpacas(GenBank EU1358800) were designed to amplify the cDNA sequence using RT-PCR to seek variation in the sequence and explore the relationship between the expression level of MC1R gene and alpaca coat color.The MC1R gene from white alpaca was cloned successfully and sequence analysis verified that the MC1R gene,encoding 317 amino acids,was 1081 bp in length.Compared with the existing sequence in GenBank,sequence identity was 99.9%and 7 mutations were found.Primers,designed from the sequence obtained,were used to assess the relative expression of MC1R in alpacas of different coat color using QRT-PCR and SPSS 13.0 software.Relative expression of MC1R in the skin of brown alpacas was 4.32 times higher than that in white alpacas after normalization with GAPDH(P【0.01),indicating that MC1R expression may be related to coat color of alpacas. 展开更多
关键词 ALPACA melanocyte-stimulating hormone receptor 1 gene(MC1R) cloning QRT-PCR gene expression level
下载PDF
上一页 1 2 15 下一页 到第
使用帮助 返回顶部